Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice

被引:5
|
作者
Greil, Waldemar [1 ,2 ]
de Bardeci, Mateo [2 ]
Seifert, Johanna [3 ]
Bernegger, Xueqiong [2 ]
Cattapan, Katja [2 ,4 ]
Stassen, Hans [2 ,5 ]
Wagner, Anita L. [2 ]
Sieberer, Marcel [3 ,6 ]
Grohmann, Renate [1 ]
Toto, Sermin [3 ]
机构
[1] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany
[2] Psychiat Private Hosp, Sanat Kilchberg, Zurich, Switzerland
[3] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany
[4] Univ Bern, Univ Hosp Psychiat & Psychotherapy, Bern, Switzerland
[5] Psychiat Univ Hosp KPPP, Inst Response Genet, Zurich, Switzerland
[6] St Marien Hosp, Dept Psychiat & Psychotherapy, Witten, Hamm, Germany
关键词
age; AMSP; dosage; drug safety; gender; major depressive disorder; overdose; psychotropic drugs; sex; TDM; SERUM CONCENTRATIONS; 2ND-GENERATION ANTIPSYCHOTICS; GENDER; PHARMACOKINETICS; VENLAFAXINE; OLANZAPINE; QUETIAPINE; ADULTS;
D O I
10.1002/hup.2809
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Several researchers have shown higher concentration-dose ratios of psychotropic drugs in women and the elderly. Therefore, lower dosages of psychotropic drugs may be recommended in women and the elderly. This study describes sex- and age-related dosage of psychotropic drugs prescribed to patients with major depressive disorder (MDD) in routine clinical practice. Method Influence of sex and age on dosages are analysed for the 10 most commonly prescribed drugs in our dataset consisting of 32,082 inpatients with MDD. Data stems from the European drug safety program "Arzneimittelsicherheit in der Psychiatrie". The observed sex and age differences in prescriptions are compared to differences described in literature on age- and gender-related pharmacokinetics. Results Among patients over 65 years, a statistically significant decrease in dosages with increasing age (between 0.65% and 2.83% for each increasing year of age) was observed, except for zopiclone. However, only slight or no influence of sex-related adjustment of dosage in prescriptions was found. Conclusion Age appears to influence adjustment of dosage in most psychotropic drugs, but to a lower extent than data on age-related pharmacokinetics suggests. Although literature also suggests that lower dosages of psychotropic drugs may be appropriate for females, this study found women are usually prescribed the same dosage as men.
引用
收藏
页数:15
相关论文
共 11 条
  • [1] Psychotropic drugs and renal failure: Translating the evidence for clinical practice
    Baghdady, Nour T.
    Banik, Suman
    Swartz, Shari A.
    McIntyre, Roger S.
    ADVANCES IN THERAPY, 2009, 26 (04) : 404 - 424
  • [2] Depression, Suicidal Ideation, and Consumption of Psychotropic Drugs During Lockdown by COVID-19 According to Gender and Age
    Villanueva-Blasco, Victor J.
    Villanueva-Silvestre, Veronica
    Vazquez-Martinez, Andrea
    Perez de Vicente, Laura
    Perez-Galvez, Bartolome
    INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2024, 22 (04) : 1859 - 1875
  • [3] Psychotropic drugs and renal failure: Translating the evidence for clinical practice
    Nour T. Baghdady
    Suman Banik
    Shari A. Swartz
    Roger S. McIntyre
    Advances in Therapy, 2009, 26 : 404 - 424
  • [4] Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice
    Baldacci, Antoine
    Saguin, Emeric
    Balcerac, Alexander
    Mouchabac, Stephane
    Ferreri, Florian
    Gaillard, Raphael
    Colas, Marie-Dominique
    Delacour, Herve
    Bourla, Alexis
    PHARMACEUTICS, 2023, 15 (11)
  • [5] Instructions for clinical and biomarker monitoring in the Summary of Product Characteristics (SmPC) for psychotropic drugs: Overview and applicability in clinical practice
    Nederlof, Mariette
    Stoker, Lennart J.
    Egberts, Toine C. G.
    Heerdink, Eibert R.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (12) : 1248 - 1254
  • [6] Clinical efficacy and changes in the dosages of concomitantly used psychotropic drugs in memantine therapy in Alzheimer's disease with behavioral and psychological symptoms on dementia
    Suzuki, Hidenobu
    Inoue, Yuichi
    Nishiyama, Akiyoshi
    Mikami, Katsunaka
    Gen, Keishi
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2013, 3 (03) : 123 - 128
  • [7] Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: Potential implications for clinical practice
    Cattaneo, Dario
    Baldelli, Sara
    Resnati, Chiara
    Giacomelli, Andrea
    Meraviglia, Paola
    Minisci, Davide
    Astuti, Noemi
    Ridolfo, Annalisa
    De Socio, Giuseppe V.
    Clementi, Emilio
    Galli, Massimo
    Gervasoni, Cristina
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2020, 21 (08) : 651 - 657
  • [8] COMPREHENSIVE TREATMENT OF MALE PSYCHOGENIC ERECTILE DYSFUNCTION BY SEX THERAPY ADN PSYCHOTROPIC DRUGS (WITHOUT PDE5 INH.)
    Nasim, Muhammad Amir Farooq
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (05) : E338 - E338
  • [9] The polysemy of psychotropic drugs: continuity and overlap between neuroenhancement, treatment, prevention, pain relief, and pleasure-seeking in a clinical setting
    Eisuke Sakakibara
    BMC Medical Ethics, 21
  • [10] Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial
    Suzuki, Hidenobu
    Gen, Keishi
    PSYCHOGERIATRICS, 2015, 15 (01) : 32 - 37